Profile data is unavailable for this security.
About the company
FIGS, Inc. operates as a direct-to-consumer healthcare apparel and lifestyle brand. The Company sells products designed to serve the particular needs of healthcare professionals primarily through its direct-to-consumer (DTC) digital platform, consisting of its Website, mobile app and B2B business (TEAMS). Its offerings include scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel. Its non-scrubwear products are designed as an integrated system that complements its scrubwear and are comprised of base layer and outer layer products. Its underscrubs include sports bras, performance leggings, performance tops and super-soft pima cotton tops. Its under underscrubs include several styles of underwear. Its outer layer products include footwear, lab coats, and a variety of vests, jackets, and fleeces. It also offers necessities, such as scrub caps, lanyards, badge reels, tote bags, baseball caps and beanies.
- Revenue in USD (TTM)544.71m
- Net income in USD22.16m
- Incorporated2013
- Employees354.00
- LocationFigs Inc2834 Colorado Avenue, Suite 100SANTA MONICA 90404United StatesUSA
- Fax+1 (302) 674-5266
- Websitehttps://www.wearfigs.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Simulations Plus Inc | 66.98m | 9.65m | 803.51m | 192.00 | 84.72 | 4.44 | 56.82 | 12.00 | 0.474 | 0.474 | 3.29 | 9.04 | 0.3603 | -- | 5.57 | 348,843.80 | 5.19 | 7.20 | 5.49 | 7.61 | 72.53 | 77.61 | 14.40 | 21.29 | -- | -- | 0.00 | 45.70 | 10.52 | 14.96 | -20.20 | 6.02 | 12.91 | 0.8548 |
| Atrion Corp | 176.67m | 18.72m | 804.48m | 712.00 | 42.99 | 3.33 | 23.49 | 4.55 | 10.63 | 10.63 | 100.32 | 137.46 | 0.6794 | 1.56 | 7.93 | 248,127.80 | 7.20 | 11.96 | 7.63 | 12.62 | 33.77 | 41.99 | 10.60 | 19.05 | 3.06 | -- | 0.00 | 42.42 | -7.73 | 2.12 | -44.55 | -10.74 | 4.98 | 11.27 |
| Cytek Biosciences Inc | 200.79m | -11.51m | 837.52m | 637.00 | -- | 2.13 | -- | 4.17 | -0.0856 | -0.0856 | 1.50 | 2.99 | 0.395 | 1.44 | 4.30 | 297,020.70 | -2.26 | -- | -2.54 | -- | 55.48 | -- | -5.73 | -- | 6.01 | -- | 0.0086 | -- | 17.67 | -- | -571.58 | -- | -- | -- |
| Standard Biotools Inc | 126.76m | -135.98m | 839.72m | 534.00 | -- | 1.50 | -- | 6.62 | -0.9957 | -0.9957 | 0.9537 | 1.52 | 0.2206 | 2.05 | 5.02 | 237,380.20 | -15.66 | -28.17 | -18.29 | -33.60 | 49.15 | 51.58 | -70.98 | -74.85 | 4.17 | -- | 0.0869 | -- | 8.57 | -1.20 | 60.73 | -- | 50.06 | -- |
| Embecta Corp | 1.13bn | 70.20m | 875.43m | 2.20k | 12.48 | -- | 8.27 | 0.773 | 1.22 | 1.22 | 19.62 | -13.35 | 0.94 | 2.51 | 15.86 | 514,772.70 | 5.83 | -- | 8.06 | -- | 65.57 | -- | 6.20 | -- | 1.79 | 2.03 | 1.89 | -- | -0.7703 | -- | -68.52 | -- | -- | -- |
| BioLife Solutions Inc | 137.30m | -62.93m | 998.77m | 409.00 | -- | 2.97 | -- | 7.27 | -1.43 | -1.43 | 3.10 | 7.30 | 0.3238 | 2.17 | 5.61 | 335,687.00 | -14.84 | -13.76 | -16.52 | -15.04 | 32.97 | 36.76 | -45.84 | -42.99 | 1.77 | -32.08 | 0.0717 | -- | -11.43 | 48.65 | 52.49 | -- | 86.35 | -- |
| Pulse Biosciences Inc | 0.00 | -42.55m | 1.03bn | 56.00 | -- | 25.60 | -- | -- | -0.8152 | -0.8152 | 0.00 | 0.6571 | 0.00 | -- | -- | 0.00 | -71.28 | -93.21 | -79.29 | -104.99 | -- | -- | -- | -12,332.25 | -- | -- | 0.00 | -- | -100.00 | -- | 27.85 | -- | -15.20 | -- |
| Avanos Medical Inc | 680.10m | -1.60m | 1.03bn | 3.77k | -- | 0.8445 | 23.59 | 1.52 | -0.0315 | -1.33 | 14.62 | 26.65 | 0.4005 | 1.62 | 5.48 | 180,350.00 | -0.0942 | -0.6527 | -0.1055 | -0.7338 | 56.33 | 54.45 | -0.2353 | -1.60 | 1.47 | 4.85 | 0.1257 | -- | -1.58 | 0.6357 | -146.05 | -- | -18.37 | -- |
| Figs Inc | 544.71m | 22.16m | 1.06bn | 354.00 | 50.24 | 2.71 | 41.70 | 1.94 | 0.1238 | 0.1238 | 3.00 | 2.29 | 1.21 | 1.10 | 118.49 | 1,538,720.00 | 4.93 | -- | 5.72 | -- | 68.56 | -- | 4.07 | -- | 3.83 | -- | 0.00 | -- | 7.87 | -- | 6.85 | -- | -- | -- |
| Silk Road Medical Inc | 185.49m | -53.42m | 1.07bn | 474.00 | -- | 7.25 | -- | 5.79 | -1.37 | -1.37 | 4.76 | 3.73 | 0.7247 | 2.08 | 7.87 | 391,322.80 | -20.87 | -29.02 | -22.75 | -32.98 | 73.31 | 72.91 | -28.80 | -46.84 | 9.62 | -- | 0.34 | -- | 27.77 | 38.66 | -1.33 | -- | -7.92 | -- |
| Artivion Inc | 368.21m | -9.58m | 1.15bn | 1.50k | -- | 3.89 | 84.14 | 3.11 | -0.2615 | -0.2615 | 8.64 | 7.07 | 0.4779 | 1.64 | 5.37 | 245,470.70 | -1.25 | -2.20 | -1.33 | -2.36 | 64.75 | 65.51 | -2.61 | -5.34 | 4.26 | 2.47 | 0.5176 | -- | 12.82 | 6.14 | -60.09 | -- | 5.13 | -- |
| AtriCure Inc | 414.60m | -37.23m | 1.15bn | 1.20k | -- | 2.53 | -- | 2.78 | -0.8005 | -0.8005 | 8.92 | 9.43 | 0.7059 | 1.70 | 8.21 | 345,501.70 | -6.34 | -3.72 | -7.08 | -4.10 | 75.26 | 74.36 | -8.98 | -7.64 | 2.83 | -10.27 | 0.1212 | -- | 20.84 | 14.64 | 34.49 | -- | 46.56 | -- |
| Owens & Minor, Inc. | 10.42bn | -38.77m | 1.17bn | 13.70k | -- | 1.31 | 4.65 | 0.1124 | -0.5099 | -0.5099 | 136.98 | 11.71 | 1.98 | 6.79 | 14.60 | 760,861.20 | -0.7372 | 1.32 | -1.11 | 2.07 | 20.75 | 16.48 | -0.3719 | 0.5614 | 0.5648 | 2.19 | 0.7065 | 0.798 | 3.80 | 1.87 | -284.47 | -- | 25.91 | -- |
| Omnicell Inc | 1.10bn | -21.05m | 1.29bn | 3.65k | -- | 1.08 | 19.62 | 1.17 | -0.461 | -0.461 | 24.19 | 25.88 | 0.4863 | 5.17 | 3.86 | 302,091.50 | -0.9283 | 1.73 | -1.15 | 2.25 | 42.63 | 46.69 | -1.91 | 2.92 | 2.13 | -- | 0.3243 | 0.00 | -11.48 | 7.82 | -460.68 | -- | 0.235 | -- |
| Establishment Labs Holdings Inc | 155.79m | -82.76m | 1.30bn | 781.00 | -- | 22.86 | -- | 8.36 | -3.15 | -3.15 | 5.91 | 2.07 | 0.6095 | 0.9191 | 3.39 | 171,579.30 | -32.38 | -33.22 | -39.25 | -41.12 | 65.01 | 64.73 | -53.12 | -43.19 | 2.73 | -21.30 | 0.7715 | -- | 2.13 | 21.96 | -4.38 | -- | 69.16 | -- |
Data as of Jul 24 2024. Currency figures normalised to Figs Inc's reporting currency: US Dollar USD
49.21%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BAMCO, Inc.as of 31 Mar 2024 | 25.73m | 15.89% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 12.25m | 7.57% |
| T. Rowe Price Investment Management, Inc.as of 31 Mar 2024 | 10.13m | 6.26% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 8.78m | 5.42% |
| Threadneedle Asset Management Ltd.as of 31 Mar 2024 | 8.63m | 5.33% |
| D. E. Shaw & Co. LPas of 31 Mar 2024 | 3.13m | 1.94% |
| Morgan Stanley & Co. LLCas of 31 Mar 2024 | 2.92m | 1.81% |
| Dimensional Fund Advisors LPas of 31 Mar 2024 | 2.71m | 1.67% |
| Marshall Wace LLPas of 31 Mar 2024 | 2.71m | 1.67% |
| Geode Capital Management LLCas of 31 Mar 2024 | 2.70m | 1.67% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
